To confirm this, we treated AE17 tumour-bearing mice 3 days after administration of ICB with antibodies against either IFNβ, IFNα (subtypes A, 1, 4, 5, 11, and 13) or their shared receptor IFNAR134. This evidence concerns the gene IFNB1 and neoplasm.